Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

RTTNews | 907天前
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

(RTTNews) - Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).

Under the terms of the agreement, Xeris will use its proprietary formulation technology platform, XeriJect, to develop an ultra-concentrated, ready-to-use, subcutaneous injection of teprotumumab and Horizon will have an option to license the Xeris technology.

Teprotumumab is the first and only medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of Thyroid Eye Disease (TED) - a serious, progressive and potentially vision-threatening rare autoimmune disease. Teprotumumab-trbw is known as TEPEZZA in the United States.

Xeris will receive an upfront payment, and may be entitled to receive development milestones, regulatory milestones, and sales-based milestones, as well as royalties based on future sales if the commercial license option is exercised. However, specific financial terms of the agreement were not disclosed.

For More Such Health News, visit rttnews.com

read more
Malaysia Stock Market Tipped To Open To The Upside

Malaysia Stock Market Tipped To Open To The Upside

The Malaysia stock market has ticked lower in back-to-back sessions, shedding almost a dozen points or 0.8 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,570-point plateau although it may find support on Monday.
RTTNews | 24分鐘前
Japan Stock Market May Find Support On Monday

Japan Stock Market May Find Support On Monday

The Japanese stock market has moved lower in three straight sessions, dropping almost 450 points or 1.3 percent along the way. The Nikkei 225 now sits just above the 37,750-point plateau although it may find traction on Monday.
RTTNews | 39分鐘前
Additional Support Expected For South Korea Shares

Additional Support Expected For South Korea Shares

The South Korea stock market bounced higher again on Friday, one day after ending the three-day winning streak in which it had advanced more than 60 points or 2.4 percent. The KOSPI now sits just above the 2,625-point plateau and it may add to its winnings on Monday.
RTTNews | 54分鐘前
China Data On Tap For Monday

China Data On Tap For Monday

China is scheduled to release a batch of data on Monday, headlining a busy day for Asia-Pacific economic activity. On Tap are April figures for industrial production, retail sales, fixed asset investment, house prices and unemployment.
RTTNews | 1小時54分鐘前